BMJ Physiotherapy Expands to One@Kentridge Medical Centre Adjacent to NUH
'We built this branch to serve patients who need continuity in care—especially right after surgery or discharge from NUH.'— Bruno Chia, Principal Physiotherapist, BMJ@One@Kentridge
SINGAPORE, CENTRAL SINGAPORE, SINGAPORE, July 20, 2025 / EINPresswire.com / -- Trusted by doctors and patients across the island, BMJ Physiotherapy has quietly opened a new clinic at One@Kentridge Medical Centre, located within the National University Hospital (NUH) compound. The West-side addition, which began operations in April 2025, offers a seamless transition for post-hospital recovery and is led by seasoned physiotherapist Bruno Chia—a name familiar to many in Singapore's healthcare and sports community.
'We built this branch to serve the needs of patients who are discharged from hospital but still need continuity in care,' says Bruno. 'One@Kentridge offers a unique opportunity—we're steps away from NUH wards, yet operate as a private practice. This gives our patients flexibility, comfort, and access to hands-on, specialist-led rehabilitation.'
From NUH to Home: The Missing Link in Recovery While NUH houses its own physiotherapy department, demand for musculoskeletal and post-operative rehab often stretches beyond availability. BMJ Physiotherapy's clinic at One@Kentridge fills this critical gap—providing direct access to physiotherapy within the same compound as the hospital.
Whether it's a senior recovering from joint replacement surgery or a young adult with a slipped disc, BMJ's West Singapore branch is designed to support recovery with minimal downtime, allowing patients to transition from hospital to home without losing treatment momentum.
Located right beside the NUH Main Building (Zone F) and accessible via Kent Ridge MRT, BMJ@One@Kentridge is also ideal for outpatient referrals from NUH doctors, private specialists, and walk-ins seeking expert care.
Google Maps: https://g.co/kgs/1qd4oJH
Leading the Team: Bruno Chia Bruno Chia, Principal Physiotherapist at BMJ@One@Kentridge, brings more than 12 years of experience treating both hospital and private sector patients. A graduate of Trinity College Dublin, he is known for his calm precision, patient-centred approach, and strong communication in English, Mandarin, and Hokkien.
His hospital background at Changi General Hospital (CGH) and Changi Sports Medicine Centre (CSMC) includes accolades such as: - CGH Best Service Award - Eastern Health Alliance Caring Award
He has served as the official physiotherapist at: - South East Asian Games 2015
- World Rugby 7s (2014)
- National Netball Super League
- Singapore Inter-Varsity Taekwondo Championship
Bruno is also a certified Exercise is Medicine Singapore practitioner, RockTape Instructor, and trained in vestibular physiotherapy, helping patients with dizziness, vertigo and balance disorders—an increasingly common condition among the elderly and post-concussive youth.
'Whether it's neck pain or post-op rehabilitation, my goal is to restore confidence in movement. Recovery isn't just physical—it's deeply emotional,' he adds.
A Patient's Words: 'I'm Finally Pain-Free After Months' One of Bruno's patients, Ms Chye Hoon Er, shared this review after being referred by her orthopaedic doctor for lower back issues:
'I had a torn disc (L4 & L5) and was in pain for months. After just a few sessions with Bruno, I could feel the improvement. He took the time to understand my condition and tailor every session to my progress. No generic exercises—only what worked for me. I'm now feeling so much better.'
This personalised care is what BMJ Physiotherapy is best known for. Each case is assessed in detail before any treatment plan is prescribed. Bruno's techniques include Myofascial Release, Muscle Energy Techniques, Joint Mobilisation, and Cognitive Behavioural Approaches—all rooted in evidence-based physiotherapy.
Services Available at BMJ@One@Kentridge - Post-Surgical Rehabilitation (Knee, Hip, Shoulder, Spine) - Vestibular & Balance Therapy (Vertigo, Dizziness) - Sports Injury Treatment & Performance Conditioning - Chronic Pain (Neck, Back, Shoulder) - Scoliosis Management (Children & Adults) - Muscle Weakness & Core Stability Programmes
With immediate appointment availability and no referral letters required, the NUH branch is ideal for patients seeking fast, reliable, and professional physiotherapy care near the hospital.
Serving West Singapore and Beyond Patients from Clementi, Holland, Bukit Timah, Buona Vista and even Jurong East have found the new clinic a welcome alternative to central locations. Its proximity to Kent Ridge MRT and bus lines makes it convenient for both weekday sessions and post-work appointments.
About BMJ Physiotherapy BMJ stands for Bones, Muscles, and Joints—and that's exactly what the team specialises in. Founded by Darek Lam, former Head of Physiotherapy at Changi Hospital, BMJ Physiotherapy is a leading physiotherapy group in Singapore with a team of therapists who are mostly former athletes and experts in manual therapy, injury prevention, and long-term rehab strategies.
BMJ currently operates six branches island wide:
BMJ@ Marine Parade:
1 Marine Parade Central, Parkway Centre, #06-03, Singapore 449408
T: +65 6871 4352 | +65 8127 4395
BMJ@Tampines:
3 Tampines Central 1, Tampines Plaza 1, #06-05, Singapore 529540
T: +65 6871 4350 | +65 9105 6648
BMJ@Ang Mo Kio:
Blk 727 Ang Mo Kio Avenue 6, #01-4254, Singapore 560727
T: +65 6871 4355 | +65 9183 5339
BMJ @Kovan/Hougang:
Blk 204 Hougang St 21, Kovan City, #01-103, Singapore 530204
T:+65 6909 5208 | +65 9181 7290
BMJ @ Kallang Wave Mall
1, Stadium Place, Kallang Wave Mall@Sports Hub. #01-79, Singapore 397628
T: +65 6871 4363 | +65 9101 5338
BMJ@One@Kentridge (NUH):
1 Lower Kent Ridge Road, #04-03/04, One@Kentridge Medical Centre, Singapore 119082
T: +65 6572 4106| +65 8690 3630
Richard Branson
Physio Asia Association
email us here
Visit us on social media:
YouTube
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Body Vision Medical Receives Pre-Market Approval for LungVision® in Singapore, Advancing AI-Powered Imaging for Early Lung Cancer Diagnosis
WALTHAM, Mass., Aug. 5, 2025 /PRNewswire/ -- Body Vision Medical, a leader in AI-powered intraoperative imaging, is pleased to announce that its LungVision advanced imaging platform has received Pre-Market Approval from Singapore's Health Sciences Authority (HSA). This clearance enables full commercialization of LungVision in Singapore and represents a significant milestone in the company's ongoing mission to improve early and accurate diagnosis of lung cancer worldwide. Lung cancer is a significant health concern in Singapore, ranking as the second most common cancer in men and the third most common in women. Over a five-year period (2018-2022), approximately 9,000 cases were diagnosed. According to the Singapore Cancer Registry, most patients are diagnosed at a late stage, reducing the effectiveness of treatment and survival rates. Improving early diagnosis with advanced imaging technology can have a meaningful impact on patient outcomes. "Receiving HSA's Pre-Market Approval is an important milestone for physicians and patients in Singapore," said Benny Krauz, Vice President of Regulatory and Quality at Body Vision Medical. "Physicians will now be able to improve the success of their diagnostic bronchoscopy procedures with real-time three-dimensional imaging, which can lead to a meaningful stage shift in lung cancer diagnostics." LungVision transforms any standard two-dimensional fluoroscopic imaging system into an AI-powered 3D imaging system, giving physicians real-time navigation and enhanced visualization to perform more precise bronchoscopic biopsies. The technology supports earlier and more accurate diagnoses of pulmonary nodules—helping improve patient outcomes while keeping procedural costs low. "Bringing LungVision to Singapore represents an important step forward in enhancing diagnostic accuracy for pulmonary care," said Daniel Soh, Managing Director for Scanmed Technology. "This platform aligns with our mission to offer high-quality, innovative solutions that improve patient care. LungVision's ability to enhance early detection and biopsy accuracy is an important advancement for pulmonary care in the region." For more information about LungVision and its availability in Singapore, please visit or contact Daniel Soh at dsoh@ About Body Vision Medical Body Vision Medical believes in saving lives through the globalization of innovative medical technology. LungVision provides AI-powered real-time image guidance to address the clinical need for early, definitive lung cancer diagnosis and to enable effective treatment of lung lesions via minimally invasive procedures. Visit to learn more and connect with us on LinkedIn. About Scanmed Technology Scanmed Technology PTE LTD is a leading medical solutions provider in Singapore, focused on bringing innovative healthcare technologies to the Singapore market. With deep industry experience and a commitment to clinical excellence, Scanmed partners with global innovators to deliver impactful solutions to healthcare professionals. Contact: Mike Hostetler +1.651.366.9584 info@ View original content: SOURCE Body Vision Medical
Yahoo
5 hours ago
- Yahoo
US-China tensions offer new opportunity for APAC biotechs, report suggests
Investors are increasingly focused on biotech companies outside of China operating in the Asia-Pacific (APAC) market, according to a report by management consulting firm Bain & Company. Homing in on Singapore specifically, the report states that rising players within the APAC region are drawing in investors through their political neutrality, protection of intellectual property (IP) and strong healthcare infrastructure. This trend is further driven by continued investment by the Singaporean Government, which has handed out $25bn in early-stage funding between 2021 and 2025 through its Research Innovation and Enterprise 2025 (RIE2025) scheme. Singapore is also aiming to bridge the gap between academia and industry through its A*STAR scheme, which is designed to encourage the translation of research into commercially viable drugs. These initiatives are designed to de-risk the early-stage development process, laying the foundations for future venture capital investment. Changing tides in the biotech sector The 2020s have been a tough period for the biotech industry, with many companies failing to obtain funding amid growing geopolitical instability and a sharpened investor focus on late-stage therapies. However, things may be looking up for the sector, with a GlobalData report finding that biotech companies obtained $8.52bn in 2024 through initial public offerings (IPOs) — a marked increase from the $5.06bn raised in 2023. Though the US and China continue to dominate the market, rising tensions between the nations could shift the balance towards politically neutral and stable nations, stated Alison Labya, senior pharma business fundamentals analyst at GlobalData. Labya said: 'Singapore's alignment with international pharmaceutical standards reduces legal and regulatory risk, increasing investor confidence in the commercial potential of innovative drugs." As the US continues to face geopolitical uncertainty, NIH funding cuts and mass regulatory layoffs, Labya noted that APAC players — particularly Singapore — are emerging as attractive alternatives for biotech investors, offering a more stable environment conducive to bringing drugs to market. Biotech's future moving forward Even amidst the growing geopolitical tensions between the US and China, Labya stated that China will likely remain the dominant force in Asian biotech. 'China remains resilient in the face of Trump's trade war, notably retaliating with 125% tariffs on US goods in April 2025,' Labya commented. Through this response, both countries reduced their import tariff rates, highlighting China's capacity to influence trade and policy outcomes. Large pharma has also continued to engage with the Chinese biotech market, with 28% of innovator drugs now being picked up from the nation, according to a report from GlobalData. For APAC countries such as Singapore to compete with China, Labya noted that biotechs in the region must penetrate the US and EU, requiring expertise into the FDA and EMA's regulatory frameworks, as well as the development of international partnerships. "US-China tensions offer new opportunity for APAC biotechs, report suggests" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
19 hours ago
- Yahoo
SportsMed Physical Therapy Opens Bellville location, Expanding to 48 Clinics Across NJ and CT
BELLVILLE, N.J., Aug. 4, 2025 /PRNewswire/ -- SportsMed Physical Therapy, a leading name in outpatient rehabilitation and wellness, is pleased to announce the opening of its newest clinic in Bellville, NJ. This addition brings the company's total number of clinics to 48, further expanding access to patient-centered care throughout New Jersey and Connecticut. This location reinforces the company's commitment to delivering accessible, high-quality care throughout the region. The Belleville clinic offers a wide range of services, including physical therapy, occupational and hand therapy, chiropractic care, acupuncture, pelvic floor physical therapy, and HomeCare services. Each treatment plan is developed with a focus on clinical excellence and personalized recovery. "We're proud to expand our footprint with the opening of our new multidisciplinary clinic in Belleville, bringing us to 48 locations across the region. This growth reflects our commitment to making high-quality, patient-centered care more accessible to the communities we serve. We look forward to becoming a trusted resource for individuals and families in these areas and continuing to deliver the outcomes our patients expect and deserve." - Peter N Ponzini, Chief Executive Officer, SportsMed Physical Therapy Since partnering with Hildred Capital Management in 2018, SportsMed has grown from 7 to 48 locations and continues to build on its mission of improving lives through movement and recovery. SportsMed is a portfolio company of Hildred Capital Management, a NYC-based investor in lower middle market healthcare companies. About SportsMed Physical Therapy SportsMed Physical Therapy is a multi-disciplinary physical therapy company with 49 locations across New Jersey and Connecticut. Since 2004, SportsMed has offered comprehensive outpatient rehabilitation and wellness services, including physical therapy, occupational/hand therapy, chiropractic care, and acupuncture services. SportsMed prioritizes offering its patients the highest quality of care possible. For more information, please visit and follow them on LinkedIn. About Hildred Capital Management Hildred Capital Management is a healthcare-focused private equity firm that seeks opportunities to create value in middle-market companies. The firm specializes in partnering with management teams to help them scale their platforms, generate earnings growth, promote strategic and operational improvements, generate business development, and drive multiple expansion. For more information, please visit and follow the firm on LinkedIn. View original content to download multimedia: SOURCE SportsMed Physical Therapy Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
